Ketorolac tromethamine salt酮咯酸

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Ketorolac tromethamine salt

CAS No. : 74103-07-4

MCE 国际站：Ketorolac tromethamine salt

产品活性：Ketorolac tromethamine salt (RS37619 tromethamine salt) 是一种非甾体抗炎剂，为非选择性的 COX 抑制剂，对 COX-1 和 COX-2 的 IC₅₀ 值分别为 20 nM 和 120 nM。

研究领域：Immunology/Inflammation

作用靶点：COX

In Vitro: Ketorolac is a non-steroidal anti-inflammatory agent, acting as a nonselective COX inhibitor, with IC₅₀s of 20 nM for COX-1 and 120 nM for COX-2.

In Vivo: Ketorolac tromethamine (0.4%) causes nearly complete inhibition on LPS endotoxin-induced increases in FITC-dextran in the anterior chamber, and increases in aqueous PGE2 concentrations in the aqueous humor in rabbits.Ketorolac (30 mg/kg, i.v.) rapidly reverses hyperalgesia in rats. Ketorolac also reduces carrageenan-induced hyperalgesia and paw PG production, and causes reduction in PGE2 levels in rats. Ketorolac (4 mg/kg/day, p.o.) has no detrimental effect in the volume fraction of bone trabeculae formed inside the alveolar socket in rats. Ketorolac (60 μg/10 μL) reduces the histological changes such as ischemic cell death, including cytoplasmic eosinophilia with disintegration of cytoarchitecture and nuclear pyknosis in rats. Ketorolac also effectively reduces neuronal death and improves hindlimb motor function, and the long-term survival is similar to that in the control group.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  CNS-Penetrant Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Anti-COVID-19 Compound Library  |  NMPA-Approved Drug Library  |  Pyroptosis Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Rare Diseases Drug Library  |  Anti-Colorectal Cancer Compound Library   |  Children’s Drug Library  |  Antidepressant Compound Library  |  Protein-protein Interaction Inhibitor Library  |  EMA-Approved Drug Library  |  FDA-Approved Anticancer Drug Library  |  Human Metabolite Library  |  Anti-Prostate Cancer Compound Library  |  Non-steroidal Anti-Inflammatory Compound Library  |  Off-patent Drug Library  |  Highly Selective Inhibitors Library  |  Acetaminophen  |  Indomethacin  |  Celecoxib  |  EIPA  |  Aspirin  |  Oxidopamine hydrobromide  |  Deferiprone  |  Diclofenac  |  Gallic acid  |  Ibuprofen  |  Catechin  |  20(S)-Ginsenoside Rg3  |  Cucurbitacin B  |  Carprofen  |  Meloxicam  |  (-)-Epicatechin  |  NS-398  |  Naproxen  |  Xanthohumol  |  Flufenamic acid  |  Salicylic acid  |  Phenacetin  |  Ketoprofen  |  SC-560  |  Rebamipide  |  Ginsenoside Rd

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds